Search Results - "Pokorny, Barbara A"
-
1
Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs
Published in Journal of Virology (15-08-2010)“…Author's Correction ( vol. 84 , p. 11599 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike…”
Get full text
Journal Article -
2
Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production
Published in PloS one (13-06-2011)“…Influenza A virus vaccines undergo yearly reformulations due to the antigenic variability of the virus caused by antigenic drift and shift. It is critical to…”
Get full text
Journal Article -
3
Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds
Published in PloS one (11-06-2013)“…Human influenza virus isolates generally grow poorly in embryonated chicken eggs. Hence, gene reassortment of influenza A wild type (wt) viruses is performed…”
Get full text
Journal Article -
4
The Total Influenza Vaccine Failure of 1947 Revisited: Major Intrasubtypic Antigenic Change Can Explain Failure of Vaccine in a Post-World War II Epidemic
Published in Proceedings of the National Academy of Sciences - PNAS (06-08-2002)“…Although vaccine-induced immunity to influenza A virus is continually challenged by progressively selected mutations in the virus's major antigens (antigenic…”
Get full text
Journal Article -
5
HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC
Published in Vaccine (15-01-2021)“…The only effective measure to decrease morbidity and mortality caused by the influenza virus in the human population is worldwide vaccination. Vaccination…”
Get full text
Journal Article -
6
Protection of Mice with Recombinant Influenza Virus Neuraminidase
Published in The Journal of infectious diseases (01-02-2004)“…Contemporary influenza vaccines are standardized with respect to their content of hemagglutinin, the major virus antigen. Although the immunizing effect of…”
Get full text
Journal Article -
7
The development of vaccine viruses against pandemic A(H1N1) influenza
Published in Vaccine (17-02-2011)“…Abstract Wild type human influenza viruses do not usually grow well in embryonated hens’ eggs, the substrate of choice for the production of inactivated…”
Get full text
Journal Article -
8
Development of high yield reassortants for influenza type B viruses and analysis of their gene compositions
Published in Vaccine (11-02-2015)“…Highlights • High yield (hy) reassortant influenza B seed viruses for vaccine production can be developed through classical reassortment of wild type (wt) B…”
Get full text
Journal Article -
9
Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs
Published in Journal of virology (01-11-2010)Get full text
Journal Article -
10
Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition
Published in Vaccine (22-02-2002)“…Influenza viruses neuraminidase (NA) were chromatographically extracted from influenza viruses A/Nanchang/933/95 H3 NCN2 NC [R] and A/Johannesburg/82/96 H1…”
Get full text
Journal Article -
11
Molecular Signature of High Yield
Published in PloS one (11-06-2013)“…Background Human influenza virus isolates generally grow poorly in embryonated chicken eggs. Hence, gene reassortment of influenza A wild type (wt) viruses is…”
Get full text
Journal Article -
12
Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds. e65955
Published in PloS one (01-06-2013)“…Background Human influenza virus isolates generally grow poorly in embryonated chicken eggs. Hence, gene reassortment of influenza A wild type (wt) viruses is…”
Get full text
Journal Article -
13
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans
Published in Vaccine (1995)“…The immunogenicity and toxicity of a purified influenza virus (N2) neuraminidase vaccine (NAV) were investigated in 88 human subjects aged 18–40, and compared…”
Get full text
Journal Article